Figure
Philadelphia Life Sciences Figures Report Q2 2023
Philadelphia Sees Reduced Activity But Poised Well for Future
July 13, 2023 3 Minute Read
Looking for a PDF of this content?
- Debt markets slowed capital transaction volumes, although deals that were already done received financing.
- Most requirements went on hold as firms struggled to raise their next round of funding. Many 2022 life science leases were inked by startups and there are fewer startups able to fund leases this year.
- Macro headwinds could slow down Philadelphia leasing, but upcoming supply is intact and perfectly timed for economic improvements by 2025.